BrightSpring Health Services, Inc. (NASDAQ:BTSG – Get Free Report) insider Jon B. Rousseau sold 531,840 shares of the stock in a transaction that occurred on Thursday, June 12th. The shares were sold at an average price of $21.75, for a total value of $11,567,520.00. Following the sale, the insider now directly owns 1,184,133 shares of the company’s stock, valued at $25,754,892.75. The trade was a 30.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.
BrightSpring Health Services Stock Performance
NASDAQ:BTSG opened at $21.18 on Friday. The company has a debt-to-equity ratio of 1.63, a current ratio of 1.35 and a quick ratio of 0.97. The business has a fifty day simple moving average of $20.74 and a two-hundred day simple moving average of $19.64. BrightSpring Health Services, Inc. has a 1 year low of $10.15 and a 1 year high of $25.57. The company has a market capitalization of $3.72 billion, a P/E ratio of -81.46 and a beta of 2.58.
BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) last released its earnings results on Friday, May 2nd. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.10. BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. The business had revenue of $2.88 billion during the quarter, compared to the consensus estimate of $2.74 billion. During the same period last year, the business posted $0.12 earnings per share. The business’s revenue for the quarter was up 25.9% on a year-over-year basis. On average, analysts expect that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current year.
Hedge Funds Weigh In On BrightSpring Health Services
Analyst Ratings Changes
A number of analysts recently commented on BTSG shares. Wells Fargo & Company increased their price target on BrightSpring Health Services from $25.00 to $27.00 and gave the company an “overweight” rating in a research report on Tuesday, May 13th. Morgan Stanley increased their price target on BrightSpring Health Services from $20.00 to $25.00 and gave the company an “overweight” rating in a research report on Friday, May 9th. Finally, Mizuho set a $26.00 price target on BrightSpring Health Services in a research report on Monday, May 5th. One analyst has rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $23.56.
Read Our Latest Analysis on BrightSpring Health Services
BrightSpring Health Services Company Profile
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Recommended Stories
- Five stocks we like better than BrightSpring Health Services
- How to Short Nasdaq: An Easy-to-Follow Guide
- Synopsys Stock Falls on China Ban, But Long-Term Outlook Holds
- Retail Stocks Investing, Explained
- Alphabet Enters a Bull Market: Is It Time to Buy?
- The Basics of Support and Resistance
- Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.